Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 5.38
+0.03 (0.56%)
Oct 31, 2025, 4:08 PM HKT
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 17.75 billion as of October 31, 2025. Its market cap has increased by 6.55% in one year.
Market Cap
17.75B
Enterprise Value
17.81B
Revenue
5.88B
Ranking
n/a
PE Ratio
38.65
Stock Price
5.38
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 17.75B, a decrease of -77.74%. That is a compound annual growth rate of -9.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 17.75B | 17.85% |
| Dec 31, 2024 | 15.06B | -10.92% |
| Dec 29, 2023 | 16.91B | -12.50% |
| Dec 30, 2022 | 19.32B | -30.93% |
| Dec 31, 2021 | 27.97B | -0.50% |
| Dec 31, 2020 | 28.11B | 3.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.34B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |